Financial reports
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
10-Q
2022 Q2
Quarterly report
10 Nov 22
NT 10-Q
Notice of late quarterly filing
16 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Oct 23
8-K
Bankruptcy or Receivership
16 Oct 23
8-K
Biocept Reports Second Quarter 2023 Financial Results
22 Aug 23
8-K
Departure of Directors or Certain Officers
21 Jun 23
8-K
Material Modifications to Rights of Security Holders
16 May 23
8-K
Biocept Reports First Quarter 2023 Financial Results
15 May 23
8-K
Biocept Reports 2022 Financial Results
17 Apr 23
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
17 Apr 23
8-K
Entry into a Material Definitive Agreement
10 Apr 23
8-K
Departure of Directors or Certain Officers
20 Mar 23
Registration and prospectus
25-NSE
Exchange delisting
20 Nov 23
424B4
Prospectus supplement with pricing info
25 May 23
S-1/A
IPO registration (amended)
23 May 23
S-1/A
IPO registration (amended)
19 May 23
S-1/A
IPO registration (amended)
16 May 23
S-1/A
IPO registration (amended)
15 May 23
S-1
IPO registration
20 Apr 23
S-8
Registration of securities for employees
8 Apr 22
424B5
Prospectus supplement for primary offering
8 Apr 22
S-8
Registration of securities for employees
16 Nov 21
Proxies
DEFR14A
Revised proxy
21 Apr 23
DEF 14A
Definitive proxy
20 Apr 23
PRE 14A
Preliminary proxy
10 Apr 23
DEFA14A
Additional proxy soliciting materials
27 Jun 22
DEFA14A
Additional proxy soliciting materials
13 Jun 22
DEF 14A
Definitive proxy
2 May 22
DEF 14A
Definitive proxy
30 Apr 21
DEFA14A
Additional proxy soliciting materials
16 Jul 20
DEFA14A
Additional proxy soliciting materials
13 Jul 20
DEFA14A
Additional proxy soliciting materials
10 Jun 20
Other
EFFECT
Notice of effectiveness
25 May 23
CORRESP
Correspondence with SEC
23 May 23
CORRESP
Correspondence with SEC
23 May 23
CORRESP
Correspondence with SEC
19 May 23
CORRESP
Correspondence with SEC
19 May 23
CORRESP
Correspondence with SEC
18 May 23
CORRESP
Correspondence with SEC
18 May 23
CORRESP
Correspondence with SEC
16 May 23
CORRESP
Correspondence with SEC
16 May 23
UPLOAD
Letter from SEC
1 May 23
Ownership
3
Robert Walsh
20 Jun 23
SC 13G
Lind Global Fund II LP
2 Jun 23
4
QUYEN THI DAO-HADDOCK
18 Nov 22
3
QUYEN THI DAO-HADDOCK
18 Nov 22
4
Marsha Alpert Chandler
8 Sep 22
4
Linda M Rubinstein
8 Sep 22
4
Bruce Gerhardt
8 Sep 22
4
IVOR ROYSTON
8 Sep 22
4
Margaret Faye Wilson
8 Sep 22
4
Darrell Taylor
4 Apr 22